Recall Notices

After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.

Additional Lot of Xembify Withdrawn
February 11, 2025
On Jan. 10, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial due to an increased rate of reported hypersensitivity reactions with the affected lot.
Learn more
Epinephrine Nasal Solution - FDA Warning
January 22, 2025
On Jan. 16, 2025, the FDA warned healthcare professionals not to use unapproved epinephrine nasal solutions from BPI Labs and Endo
Learn more
One Lot of Xembify Withdrawn
January 17, 2025
On Jan. 13, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial
Learn more
Systane Eye Drops Recalled
December 30, 2024
On Dec. 21, 2024, Alcon Laboratories recalled one lot of Systane® Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count to the consumer level.
Learn more
Adrenalin Recalled
December 30, 2024
On Dec. 20, 2024, Endo, Inc., the parent company of Par Pharmaceutical, recalled six lots of Adrenalin® Chloride Solution
Learn more
Clonazepam Orally Disintegrating Tablets Recall
November 22, 2024
On Nov. 19, 2024, Endo Pharmaceuticals, the parent company of Par Pharmaceuticals, notified the FDA of an expansion of its voluntary recall of Clonazepam Orally Disintegrating Tablets
Learn more
Cinacalcet Recall
October 30, 2024
On Oct. 9, 2024, Dr. Reddy’s recalled all lots and expiration dates for cinacalcet 30mg, 60mg and 90mg tablets.
Learn more
Veklury Recalled
October 08, 2024
On Sept. 20, 2024, Gilead Sciences recalled one lot of Veklury® (remdesivir) for injection 100mg/vial.
Learn more
Atovaquone Recalled
October 08, 2024
On Sept. 17, 2024, Bionpharma Inc. recalled one lot of Atovaquone Oral Suspension because it was found to be contaminated with the bacteria Cohnella.
Learn more
Medical Device Correction for FreeStyle Libre 3 Sensors
September 16, 2024
On July 24, 2024, Abbott Diabetes Care, Inc. issued a medical device correction for FreeStyle Libre 3 Sensors because they can give an incorrectly high glucose reading, posing a potential health risk for people with diabetes.
Learn more

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.